Featured Image
October 29, 2017

Hunt to Stop a Killer

Nearly 25 years after the Huntington’s disease gene discovery, treatments to curb the condition appear within reach.

by Kendall K. Morgan
Featured Image
Featured Image
Policy

Insuring Costly Orphan Drugs

Anthem’s decision to cover a $300,000 per year medication for Duchenne muscular dystrophy still has some caveats.

Current Issue


Family

Modern Family Planning

Expanded carrier screening now allows couples to test for hundreds of recessive disorders pre- and post-conception.

by Sonya Collins•October 29, 2017
Cover Story

Turning Point

The FDA’s approval of an anti-cancer drug prescribed based on a tumor’s genetic glitches rather than its location is a landmark in precision medicine.

by Kendall K. Morgan•October 29, 2017
Research

Decoding the Immune System

By deciphering the DNA of core immune structures, the Human Immunome Program is set to transform disease diagnosis, prevention, and treatment.

by Maureen Salamon•October 29, 2017
Featured Stories

Cover Story

Are Antibiotics
Making Us Fat?

The microbes we’re missing may play a role in America’s weight problem and in other diseases of modern life.

by Kendall K. Morgan•July 6, 2015
Deep Dive

Common Thread

Celiac disease’s shared genetics and biology with other autoimmune disorders may lead the way to more treatments for all.

by Katy Human•April 5, 2016

Columns


Extreme Parenting
Kasey Edwards

Extreme Parenting

How the mothers and fathers of children with ultra rare disorders spearhead their own support and research strategies.

Research


Featured Image
Research

Decoding the Immune System

By deciphering the DNA of core immune structures, the Human Immunome Program is set to transform disease diagnosis, prevention, and treatment.

Featured Image
Research

To Boldly Go

What science could learn from NASA’s Twins Study.

Treatment


Featured Image
Treatment

Seeing Into the Future

The first gene therapy for hereditary blindness is close to approval.

Featured Image
Treatment

Big Data Meets Big Doo-doo

Stool transplant registry will be the largest data set of long-term outcomes.

Featured Image
Treatment

FDA Says Yes to Yescarta

The second gene therapy approved for cancer is aimed at treating adults with certain types of non-Hodgkin lymphoma.

Get The Magazine

Fall 2017
No 14
Fall 2017

Subscribe Today

Don’t miss a single story. From genetics research, innovative treatments, and comprehensive deep dives we are the source for genetics in science and medicine.

Your life may depend on it.

Latest